Pharmaceutical News

RSS

Research paves way for clinical trials of existing drugs for brain metastasis

The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease.

29 Nov 2023

Study finds no evidence to suggest cannabis reduces illicit opioid use

A 20-year Australian study has found no evidence to suggest cannabis reduces illicit opioid use, and it may not be an effective long-term method of reducing harm for those with an opioid use disorder or problematic use of opioids.

29 Nov 2023

People using ADHD medicines for a long time may have higher risk of cardiovascular diseases

A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year.

29 Nov 2023

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Study reveals that pregnant women infected with COVID-19 had a higher risk of preterm delivery, with significant health and socioeconomic implications. However, early vaccination adopters showed protection from these effects, highlighting the critical role of vaccines in safeguarding future generations' health, especially in the U.S., where the study was conducted.

28 Nov 2023

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Scientists have discovered new antiviral compounds from a rare bacterial strain, offering a novel approach to target hepatitis B virus. These compounds work by altering membrane permeability in infected cells, leading to the release of immature viral particles, a mechanism distinct from current HBV treatments.

28 Nov 2023

Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

28 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.

27 Nov 2023

1 in 10 prescription drugs has industry-sponsored patient support program

About 1 in 10 prescription drugs - mainly brand-name and expensive drugs and those for rare diseases - has a manufacturer-sponsored patient support program, which usually includes financial, nursing and educational supports.

27 Nov 2023

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

23 Nov 2023

Curbing pharmaceutical effluent pollution: A crucial step in fighting antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat, especially in low- and middle-income countries (LMICs), causing prolonged illnesses, heightened antimicrobial use, increased healthcare expenses, and avoidable deaths.

23 Nov 2023

Sickle Cell Disease patients and the use of disease-modifying treatments

New disease-modifying treatments (DMTs), namely, crizanlizumab, L-glutamine, and voxelotor, have recently been approved.

23 Nov 2023

Numbing agent lidocaine may have cancer-fighting properties

Lidocaine - often used as numbing agent for outpatient medical procedures - activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

22 Nov 2023

Repurposed drugs hold promise for targeting cancer stem cells

In a review published in the journal Genes & Diseases, researchers from ICMR-National Institute of Nutrition (NIN), advocate for the repurposing of non-cancer drugs to target these elusive CSCs.

22 Nov 2023

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine.

22 Nov 2023

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Call for improved data sharing practices in the pharmaceutical industry

Previous
1
...
40
41
42
43
44
45
46
...
1443
Next

Pharmaceutical News

Research paves way for clinical trials of existing drugs for brain metastasis

Study finds no evidence to suggest cannabis reduces illicit opioid use

People using ADHD medicines for a long time may have higher risk of cardiovascular diseases

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

1 in 10 prescription drugs has industry-sponsored patient support program

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Curbing pharmaceutical effluent pollution: A crucial step in fighting antimicrobial resistance

Sickle Cell Disease patients and the use of disease-modifying treatments

Numbing agent lidocaine may have cancer-fighting properties

Repurposed drugs hold promise for targeting cancer stem cells

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Call for improved data sharing practices in the pharmaceutical industry

Evolving overdose crisis shakes previously effective treatments

Study highlights rise in pain medication dependence due to medical negligence

Novel antidepressant zuranolone effective in alleviating depression and anxiety symptoms

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News